Treatment of pancreatic cancer cell line HPDE6-C7 with RP02-1 increased CASP3 activity and the BCL2-associated X apoptosis regulator (Bax) to BCL2 apoptosis regulator (Bcl-2) ratio but reduced chromatin condensation. This evidence concerns the gene BCL2 and pancreatic neoplasm.